After the bonanza of 2021, life-sciences entrepreneurs reset their expectations as financing contracted

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acelyrin, Adcendo, Algernon, Bayer, Boehringer Ingelheim, Caris, Celmatix, Duality, Esperovax, Evotec, Ginkgo, Lumen, Merck & Co., Nouscom, Orbit, Orna, Paratek, Phoremost, Sanegene, Simnova Xianbo, Triumvira, Variational Ai, Xencor, Y-Mabs.

Read Complete Article

Triumvira Immunologics Establi .. [Tales From the 2022 Biotech VC ..](/content/tales-from-the-2022-biotech-vc-fundraising-trail/ "Tales From the 2022 Biotech VC Fundraising Trail"/index.html)